ArticleAnnals of hematology2021
Low-dose ruxolitinib shows effective in treating myelofibrosis.
Yunfan Yang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleAnnals of hematology2021
Yunfan Yang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.